Overview
Cardiogen is a synthetic tetrapeptide classified as a Khavinson bioregulator, originally developed in Russia at the St. Petersburg Institute of Bioregulation and Gerontology. Unlike typical supplements that address systemic symptoms, Cardiogen functions at the genetic level. It is small enough to penetrate the cell nucleus, where it interacts directly with DNA to normalize protein synthesis in heart tissue. This makes it a specialized tool for restoring cellular function rather than just providing temporary stimulation.
In the context of physical performance, Cardiogen is primarily used to protect and repair the heart muscle from the stressors of high-intensity training and the use of performance-enhancing compounds. By inhibiting the overgrowth of fibroblasts (which lead to scarring) and supporting the health of heart muscle cells, it helps maintain cardiac elasticity and efficiency. It is often utilized by athletes and biohackers looking to optimize cardiovascular recovery and long-term heart health.
Mechanism of action
A tetrapeptide (AEDR) that acts as an epigenetic modulator, binding to specific DNA promoter regions to regulate genes involved in cardiac repair and protein synthesis.
Reported benefits
- ▸Supports heart muscle (cardiomyocyte) regeneration and repair
- ▸Reduces fibrotic buildup and stiff scar tissue in cardiac tissue
- ▸Enhances oxygen utilization and overall endurance during exercise
- ▸Improves blood flow through endothelial cell support
- ▸Helps mitigate cardiotoxic strain from stimulants or PEDs
- ▸Promotes healthy collagen structure within the cardiovascular system
Reported side effects
- ·Mild fatigue
- ·Temporary blood pressure fluctuations
- ·Redness at injection site
Often stacked with
VilonVesugenThymogenBPC-157TB-500